Exxon Q3 beat and buyback don't change cyclically rich valuation

What happened

Seeking Alpha touts Exxon's Q3 earnings, free cash flow, $20B buyback for next year, and 4% dividend hike as a 'no-brainer blue-chip energy buy' amid high petroleum prices and refinery margins. The DeepValue master report had already rated Exxon a POTENTIAL SELL at $157 with conviction 4, citing 26.6x earnings, 10.2x EV/EBITDA, and EIA forecasts of Brent falling to $65/bbl in 2027. The strong Q3 results are consistent with the report's warning that near-term earnings are heavily tied to cyclical oil and refining conditions that may not persist. The announced $20B buyback for next year is not new: management had already guided to $20B of buybacks in 2026 assuming reasonable market conditions, so it mainly confirms capital return appetite at potentially inflated prices. While Permian production growth is real, it does not offset the valuation risk if commodity prices normalize, and the article's 'Strong Buy' ignores the report's identified downside scenario of $138 per share.

Implication

Investors should treat the Seeking Alpha piece as retail-flow hype rather than incremental fundamental proof, because it celebrates cyclical peak earnings without addressing the normalized 2027 environment. The $20B buyback next year and dividend increase signal management's confidence but do not change the fact that the stock trades at 26.6x earnings and 10.2x EV/EBITDA, levels that already price in quality. If Brent averages $65 in 2027 as EIA forecasts, Exxon's earnings power likely declines, and the current valuation leaves little margin of safety. The key checkpoints remain Uaru startup in 2026 and Golden Pass Train 2 ramp in 2H26; without those, the growth offset is insufficient. On a pullback to the $142 attractive entry identified in the master report, or after confirmation that advantaged volumes can offset macro weakness, the stock becomes more attractive for accumulation.

Thesis delta

The Q3 beat and buyback announcement do not alter the core thesis: Exxon remains a high-quality cyclical whose current earnings are inflated by oil and refining margins that EIA expects to normalize. The article's 'no-brainer' call relies on extrapolating cyclical peak conditions and ignores the valuation and the $138 bear case. Thesis remains POTENTIAL SELL; if anything, the stock's rise toward new highs makes trimming more urgent.